Phillips; Gail Lewis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Phillips; Gail Lewis.The latest application filed is for "combination therapy with an anti-her2 antibody-drug conjugate and a bcl-2 inhibitor".

Company Profile

7.7.15

Phillips; Gail Lewis - South San Francisco CA
Phillips; Gail Lewis - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy With An Anti-her2 Antibody-drug Conjugate And A Bcl-2 Inhibitor App 20210213130 - Phillips; Gail Lewis ; et al.	2021-07-15
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor Grant 10,898,570 - Phillips , et al. January 26, 2	2021-01-26
Anti-HER2 Antibodies and Immunoconjugates App 20200255539 - Kind Code	2020-08-13
Immunoconjugates Comprising Anti-HER2 Antibodies and Pyrrolobenzodiazepines App 20200085840 - Chen; Xiaocheng ; et al.	2020-03-19
Anti-HER2 antibodies and immunoconjugates Grant 10,556,966 - Chen , et al. Feb	2020-02-11
Anti-HER2 Antibodies and Immunoconjugates App 20190177429 - Chen; Xiaocheng ; et al.	2019-06-13
Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines Grant 10,314,846 - Chen , et al.	2019-06-11
Anti-HER2 antibodies and immunoconjugates Grant 10,179,820 - Chen , et al. Ja	2019-01-15
Combination Therapy With An Anti-her2 Antibody-drug Conjugate And A Bcl-2 Inhibitor App 20180140700 - Phillips; Gail Lewis ; et al.	2018-05-24
Immunoconjugates Comprising Anti-her2 Antibodies And Pyrrolobenzodiazepines App 20170274092 - Chen; Xiaocheng ; et al.	2017-09-28
Anti-her2 Antibodies And Immunoconjugates App 20170174782 - Chen; Xiaocheng ; et al.	2017-06-22
Anti-HER2 antibodies and immunoconjugates Grant 9,518,118 - Chen , et al. December 13, 2	2016-12-13
Anti-her2 Antibodies And Immunoconjugates App 20160096893 - Chen; Xiaocheng ; et al.	2016-04-07
Combinations Of An Anti-her2 Antibody-drug Conjugate And Chemotherapeutic Agents, And Methods Of Use App 20140140993 - Ross; Leanne Berry ; et al.	2014-05-22
Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use Grant 8,663,643 - Berry , et al. March 4, 2	2014-03-04
Combinations Of An Anti-her2 Antibody-drug Conjugate And Chemotherapeutic Agents, And Methods Of Use App 20120107302 - Berry; Leanne ; et al.	2012-05-03
Apo-2 ligand-anti-Her-2 antibody synergism App 20080241146 - Ashkenazi; Avi J. ; et al.	2008-10-02
Apo-2 ligand-anti-her-2 antibody synergism App 20080160026 - Ashkenazi; Avi J. ; et al.	2008-07-03
APO-2 ligand-anti-her-2 antibody synergism App 20070026001 - Ashkenazi; Avi J. ; et al.	2007-02-01
Apo-2 ligand-anti-Her-2 antibody synergism App 20050244417 - Ashkenazi, Avi J. ; et al.	2005-11-03
Apo-2 ligand-anti-Her-2 antibody synergism App 20020141993 - Ashkenazi, Avi J. ; et al.	2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.